Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
Market Capitalization	239	277	363	469	871	501
Market Cap Growth	-40.64%	-23.67%	-22.48%	-46.17%	73.82%	15.35%
Enterprise Value	339	314	358	380	787	493
Last Close Price	0.11	0.13	0.17	0.21	0.39	0.21

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
Forward PE	-	6.55	6.55	6.55	6.55	6.55
PS Ratio	0.68	0.86	1.10	0.88	1.59	0.98
PB Ratio	0.54	0.61	0.72	0.79	1.33	0.64
P/TBV Ratio	0.83	0.79	0.94	0.95	1.64	0.79
P/FCF Ratio	-	38.63	-	-	12.69	-
P/OCF Ratio	-	19.76	-	-	8.55	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
EV/Sales Ratio	0.97	0.97	1.09	0.71	1.44	0.97
EV/FCF Ratio	-	43.76	-	-	11.47	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
Debt / Equity Ratio	0.33	0.29	0.25	0.19	0.22	0.20
Debt / EBITDA Ratio	-	-	-	20.85	-	-
Debt / FCF Ratio	-	18.48	-	-	2.06	-
Net Debt / Equity Ratio	0.23	0.13	0.07	-0.10	-0.34	-0.24
Net Debt / EBITDA Ratio	-4.99	-2.63	-1.46	60.10	8.04	6.46
Net Debt / FCF Ratio	-	8.53	-1.17	0.58	-3.27	3.09
Asset Turnover	0.46	0.43	0.39	0.53	-	0.44
Inventory Turnover	3.79	4.47	3.38	4.88	-	3.86
Quick Ratio	0.44	0.63	0.69	0.89	1.40	1.83
Current Ratio	0.68	0.83	0.86	1.10	1.54	2.13
Return on Equity (ROE)	-14.89%	-14.61%	-11.19%	-4.01%	-	-2.74%
Return on Assets (ROA)	-4.12%	-4.47%	-4.02%	-1.81%	-	-2.40%
Return on Invested Capital (ROIC)	-9.28%	-10.22%	-10.06%	-6.02%	-13.65%	-6.81%
Return on Capital Employed (ROCE)	-10.80%	-10.60%	-10.50%	-4.80%	-9.70%	-4.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Aug 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
Earnings Yield	-28.92%	-25.24%	-16.89%	-5.15%	-6.27%	-3.95%
FCF Yield	-	2.59%	-8.34%	-21.13%	7.88%	-12.37%
Dividend Yield	-	-	-	1.22%	0.89%	1.21%
Total Shareholder Return	-	-	-	1.22%	0.89%	1.21%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error